Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World.

Autor:	Hirschfeld CB; Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA., Shaw LJ; Weill Cornell Medical College and New York-Presbyterian Hospital, New York, New York, USA., Williams MC; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom., Lahey R; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA., Villines TC; Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Dorbala S; Departments of Medicine and Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Choi AD; George Washington University School of Medicine, Washington, DC, USA., Shah NR; Division of Cardiology, Department of Medicine, Brown University Alpert Medical School, Providence, Rhode Island, USA., Bluemke DA; Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Madison, Wisconsin, USA., Berman DS; Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Blankstein R; Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ferencik M; Division of Cardiovascular Medicine, Oregon Health and Science University School of Medicine, Portland, Oregon, USA., Narula J; Mount Sinai Medical Center, New York, New York, USA., Winchester D; Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida, USA., Malkovskiy E; Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA., Goebel B; Weill Cornell Medical College and New York-Presbyterian Hospital, New York, New York, USA., Randazzo MJ; Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA., Lopez-Mattei J; Departments of Cardiology and Thoracic Imaging, MD Anderson Cancer Center, Houston, Texas, USA., Parwani P; Department of Cardiology, Loma Linda University Health, Loma Linda, California, USA., Vitola JV; Quanta Diagnostico por Imagem, Curitiba, Paraná, Brazil., Cerci RJ; Quanta Diagnostico por Imagem, Curitiba, Paraná, Brazil., Better N; Royal Melbourne Hospital and University of Melbourne, Victoria, Australia., Raggi P; Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada., Lu B; National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China., Sergienko V; National Medical Research Center of Cardiology of Health care Ministry, Moscow, Russian Federation., Sinitsyn V; University Hospital, Lomonosov Moscow State University, Moscow, Russian Federation., Kudo T; Nagasaki University, Nagasaki, Japan., Nørgaard BL; Aarhus University Hospital, Aarhus, Denmark., Maurovich-Horvat P; Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary., Cohen YA; Technion Israel Institute of Technology, Haifa, Israel., Pascual TNB; Philippines Nuclear Research Institute, Manila, Philippines., Pynda Y; International Atomic Energy Agency, Vienna, Austria., Dondi M; International Atomic Energy Agency, Vienna, Austria., Paez D; International Atomic Energy Agency, Vienna, Austria., Einstein AJ; Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA; Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, USA. Electronic address: andrew.einstein@columbia.edu.
Jazyk:	angličtina
Zdroj:	JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2021 Sep; Vol. 14 (9), pp. 1787-1799. Date of Electronic Publication: 2021 Jun 16.
DOI:	10.1016/j.jcmg.2021.03.007
Abstrakt:	Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection. Competing Interests: Funding Support and Author Disclosures This work was supported by the International Atomic Energy Agency. Dr. Blankstein has previously received research support from Amgen and Astellas Inc. Dr. Ferencik has been previously supported by U.S. National Institutes of Health (NIH) and American Heart Association; and is a consultant for Biograph, Inc. Dr. Nørgaard has previously received unrestricted institutional research grants from Siemens and HeartFlow. Dr. Maurovich-Horvat has been a shareholder of Neumann Medical Ltd. Dr. Einstein has previously received grants from NIH, International Atomic Energy Agency, Canon Medical Systems, Roche Medical Systems, WL Gore, and GE Health care; consultant for WL Gore; on the Speakers Bureau for Ionetix; has received travel/accommodations/meeting expenses from HeartFlow; and is a stockholder in Emergent BioSolutions Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu